By: Leslie Lopez According to CNN, The CDC and the FDA recommend the U.S to stop using Johnson & Johnson for complication results. There have been over six reports in the U.S of “rare and severe” blood clots due to Johnson & Johnson. In those reports a 45 year old woman died and another is in critical condition. The cases were all women between the ages 18 to 48 and they showed symptoms after 6 to 13 days of their vaccination. Johnson & Johnson has decided to pause the vaccine until the FDA does a thorough investigation. The CDC wants people who have taken Johnson & Johnson within the month to watch for these symptoms: severe heachache that does not go away, shortness of breath, abdominal and leg pain that keeps occurring. Chances of getting the blood clot are low for the people who have received the Johnson & Johnson vaccine more than a month ago. The six women developed a cerebral venous sinus thrombosis, which is a blood clot in the brain. The pause in the vaccine will allow the CDC and FDA to understand the causes of the blood clots and the individual histories of the people that were involved. Cerebral venous sinus thrombosis affects one in five million a year and people may experience stroke like symptoms. The CDC is not sure on how long the pause will last but right now they want to get all the possible information they can get. With that being said it is said that Pfizer’s is 100% effective. It shows that it is tolerated in youths ages between 12 and 15. In their third trial teenagers showed strong antibodies after their second dose. The vaccine is currently available for the ages 16 and older.
0 Comments
Your comment will be posted after it is approved.
Leave a Reply. |
StaffLearn more about the people behind the stories by clicking the button below. Archives
October 2023
Categories |